Correlation Between Influencer Endorsements and Increased Prescription Rates of Non-Validated Oncology Treatments
Introduction
A recent academic study indicates a significant rise in the prescription of ivermectin and benzimidazole derivatives following public endorsements by high-profile individuals on digital media platforms.
Main Body
The phenomenon originated from a January 2025 broadcast of 'The Joe Rogan Experience,' during which actor Mel Gibson asserted that ivermectin and fenbendazole had facilitated the recovery of associates with stage-four malignancy. This anecdotal testimony coincided with a quantitative shift in pharmaceutical procurement. Data analyzed by researchers from Virginia Tech, UCLA, and the University of Michigan—published in JAMA Network Open—demonstrate that prescriptions for these agents doubled across the general patient population during the first seven months of 2025 relative to the preceding year. Notably, the rate of prescription among oncology patients increased by a factor of 2.5. Demographic analysis reveals that the surge was most pronounced among males, white patients, and residents of the Southern United States, a distribution that aligns with the primary audience of the aforementioned podcast. While ivermectin is indicated for parasitic infections and fenbendazole remains unapproved for human consumption, the researchers posit that the susceptibility of patients with life-threatening conditions to unproven therapies may result in the deferral of conventional clinical interventions. This trend is further contextualized by Pew Research data indicating that 50% of U.S. adults under 50 derive health information from non-medical influencers. Consequently, the institutional challenge persists in mitigating the impact of pseudoscience disseminated via high-reach digital channels, despite previous attempts by platforms such as Spotify to implement content advisory labels.
Conclusion
The current situation reflects a growing reliance on non-clinical information sources, leading to a measurable increase in the use of unproven medical treatments.
Learning
The Architecture of Academic Detachment
To transition from B2 to C2, a student must move beyond 'formal' language and master Nominalization—the process of turning verbs or adjectives into nouns to create an objective, 'de-personalized' academic tone. This text is a masterclass in stripping the human agent to emphasize the phenomenon.
🔍 The Pivot from Action to Concept
Observe how the author avoids saying "People started prescribing more drugs" or "The podcast made people buy them." Instead, we see:
"...a quantitative shift in pharmaceutical procurement."
C2 Analysis:
- Action: Procure (Verb) Concept: Procurement (Noun).
- Effect: By converting the action into a noun, the writer removes the 'actor' and focuses on the 'trend'. This is the hallmark of high-level scholarly writing: it shifts the focus from who did it to what happened.
🛠️ Linguistic Engineering: The "Noun-Heavy" Chain
C2 mastery involves constructing complex noun phrases that pack immense data into a single subject. Look at this sequence:
"...the susceptibility of patients with life-threatening conditions to unproven therapies..."
If a B2 student wrote this, they might say: "Patients have life-threatening conditions, so they are susceptible to therapies that aren't proven."
The C2 Upgrade:
- B2: (Subject) (Verb) (Object).
- C2: (Complex Noun Phrase) (Single Verb) (Complement).
🖋️ Lexical Precision: The 'Nuance' Gap
Note the use of "indicated for" and "posited."
- Indicated for: In a medical C2 context, this doesn't mean 'suggested'; it refers to the official FDA/regulatory approval for a specific use.
- Posit: Far more sophisticated than 'suggest' or 'think'. To posit is to put forward an argument as a basis for further reasoning.
Strategic Takeaway: To achieve C2, stop describing actions. Start describing concepts. Replace "The prices went up quickly" with "A rapid escalation in pricing occurred."